Biolex Therapeutics

Biolex is a clinical-stage biopharmaceutical company that uses its proprietary LEX System (SM) to develop difficult-to-manufacture therapeutic proteins and optimize monoclonal antibodies. The LEX System is a new technology capable of genetically transforming the aquatic plant Lemna to produce candidate biologics.